Artesunate Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 110 mg per vial
Reference Brands: Generic formulations marketed under different names
Category:
Critical Care
Artesunate is a fast-acting antimalarial drug from the artemisinin class, used for the treatment of severe malaria caused by Plasmodium falciparum. It works by rapidly killing parasites in the blood, reducing disease severity and preventing complications. Artesunate is available as intravenous injections, oral tablets, and rectal suppositories, often used in combination therapies to improve efficacy and prevent resistance.
Artesunate is available in Injection
and strengths such as 110 mg per vial.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Artesunate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Artesunate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing